L'Associazione medica turca indaga sulla pubblicità della "circoncisione femminile" da parte dei medici

The Turkish Medical Association (TTB) has initiated a disciplinary investigation against a doctor accused of promoting and advertising female genital mutilation (FGM) on social media. The TTB stated in a written statement that the practice is illegal and contravenes medical ethics and human rights. According to the association, FGM constitutes a severe form of violence that infringes upon the bodily integrity, health, and fundamental human rights of women and girls. It emphasized that there is no medical necessity or scientific foundation for the procedure, and it is explicitly condemned by international health and human rights organizations, notably the World Health Organization. The investigation was launched following reports that the doctor, whose identity has not been disclosed, claimed to perform and promote FGM procedures online. While the TTB did not specify the region where the investigation is taking place, it indicated that the relevant medical chamber has begun disciplinary proceedings. The association reiterated its commitment to upholding medical ethics, scientific principles, and human rights, stating it will monitor the legal and disciplinary actions closely. Female genital mutilation refers to the partial or complete removal of external female genitalia or other harmful procedures affecting the genital area without medical justification. This practice is widely recognized as a violation of human rights and poses serious health risks. According to the World Health Organization and UNICEF, over 230 million women and girls globally have undergone FGM. The procedure is predominantly found in regions of Africa, including Somalia, Egypt, Sudan, Guinea, Djibouti, Mali, and Ethiopia. It is also practiced in some Middle Eastern countries such as Iraq and Yemen, as well as in parts of Southeast Asia, including Indonesia and Malaysia. Cultural, traditional, or religious beliefs often justify the continuation of FGM, despite its harmful consequences. The procedure can lead to severe complications such as excessive bleeding, infections, infertility, and psychological distress. In extreme cases, it can result in life-threatening conditions during childbirth. These effects underscore the urgent need for awareness campaigns and legal measures aimed at preventing the practice. The TTB’s decision reflects growing concerns within the medical community regarding the ethical implications of such practices. While the association has not yet released further details about the case, the move signals a broader effort to address the issue of unethical medical advertising and its potential impact on public health. The disciplinary process will likely involve reviewing the doctor's conduct, assessing whether the advertisements violated professional standards, and determining appropriate sanctions if necessary. As the investigation unfolds, the TTB is expected to provide updates on the status of the case and any subsequent actions taken. The association has also called for continued vigilance in protecting patients' rights and ensuring that medical professionals adhere strictly to ethical guidelines. With global attention on human rights and gender equality, the outcome of this case could influence future policies and educational efforts aimed at eradicating FGM.